Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype and is characterized by poor survival. Radiotherapy plays an important role in treating TNBC. The purpose of this study was to determine whether inhibiting the AMP-activated protein kinase (AMPK) and phosphatidylinosit...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Jeremy, Chow, Zeta, Napier, Dana, Lee, Eun, Weiss, Heidi L., Evers, B. Mark, Rychahou, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291172/
https://www.ncbi.nlm.nih.gov/pubmed/32438621
http://dx.doi.org/10.3390/cells9051253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291172/
https://www.ncbi.nlm.nih.gov/pubmed/32438621
http://dx.doi.org/10.3390/cells9051253

Ejemplares similares